3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
5
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Cardiovascular Diseases
2
Triple Negative Breast Neoplasms
1
Prostatic Intraepithelial Neoplasia
1
Osteoporosis
1
Neuralgia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Eye Diseases
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Bone Diseases, Metabolic
1
Interventions
Exercise
4
Walking
2
Memantine
2
Donepezil
2
beta Carotene
1
Vitamin E
1
Ultraviolet Therapy
1
Time
1
Tai Ji
1
Surveys and Questionnaires
1
Sugars
1
Standard of Care
1
Sirolimus
1
Riluzole
1
Rehabilitation, Vocational
1
Referral and Consultation
1
Ramipril
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Population Groups
1
Pioglitazone
1
Palliative Care
1
Neuropsychological Tests
1
Mindfulness-Based Stress Reduction
1
Methods
1
Interviews as Topic
1
Ibuprofen
1
Hormones
1
Hematologic Tests
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cognitive Dysfunction
×
Geritol
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled